People taking anti-inflammatory drug mount a weaker immune response to COVID-19 vaccine

By | June 3, 2021
One-quarter of people who take the drug methotrexate for common immune system disorders — from rheumatoid arthritis to multiple sclerosis — mount a weaker immune response to a COVID-19 vaccine, a new study shows.